Physician profile
Sara Walters
NPI 1346594132
$1,438.97
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $484 · 2023: $738 · 2024: $14.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $280.11 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $264.91 | 2022-2023 | Mounjaro, Trulicity, Emgality |
| Novartis Pharmaceuticals Corporation | $216.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $121.15 | 2022-2023 | Verquvo, Steglatro, Belsomra |
| Exact Sciences Corporation | $67.44 | 2023 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $50.25 | 2023 | Rexulti |
| Amgen INC. | $41.67 | 2021-2023 | Repatha, Otezla |
| Nestle Healthcare Nutrition INC. | $35.76 | 2021 | |
| Glaxosmithkline, LLC. | $31.65 | 2023 | Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $28.53 | 2021 | |
| Amarin Pharma, INC. | $27.18 | 2021-2022 | |
| Horizon Therapeutics Plc | $21.85 | 2023 | Krystexxa |
| Axsome Therapeutics, INC. | $21.73 | 2023 | Sunosi |
| Astrazeneca Pharmaceuticals Lp | $20.32 | 2023 | Fasenra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.55 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $19.43 | 2023 | Zilretta |
| Philips North America LLC | $19.35 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.06 | 2022 | |
| Abbott Laboratories | $18.05 | 2022 | |
| Astellas Pharma US INC | $16.37 | 2023 | Veozah |
| Insmed, INC. | $16.22 | 2021 | |
| Pfizer INC. | $15.75 | 2023 | |
| Abbvie INC. | $14.45 | 2022 | |
| W. L. Gore & Associates, INC. | $14.37 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| E.R. Squibb & Sons, L.L.C. | $14.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.15 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.